PGD2R antagonist OC000459 vs placeboWithdrawals due to adverse events · active EoE patients1 finding from 1 reviewMedical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 26 participantsVery low